Decanoyl-RVKR-CMK (DecRVKRcmk) TFA inhibits over-expressed gp160 processing and HIV-1 replication In Vitro Decanoyl-RVKR-CMK (DecRVKRcmk) TFA inhibits HIV-2 ROD replication by blocking envelope glycoprotein precursor processing in the Jurkat lymphocyte cell. ? Decanoyl-RVKR-CMK (DecRVKRcmk) TFA blocks regulated secretion of VGF. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability AssayCell Line: HeLaCD4 cells infected with recombinant vaccinia viruses at a multiplicity of infection (MOI) of 5 PFU/mL Concentration: 35 and 70 µΜ Incubation Time: 7 days Result: Peptide at 35 µM significantly inhibited ex vivo HIV-1 and HIV-2 replications (70-80% inhibition). Form:Solid IC50& Target:HIV-1 HIV-2
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Decanoyl-RVKR-CMK TFA
CAS number：2098497-25-5 molecular formula：C36H67ClF3N11O7
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | - | ||
| CAS number | 2098497-25-5 | molecular formula | C36H67ClF3N11O7 |
| molecular weight | 858.43 g/mol | Exact mass | ≥96% |
| PSA | - | logp | - |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
